4 news items
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
into, and successfully complete, clinical trials; and our plans and strategy regarding maintaining existing and entering into new collaborations and/or partnerships
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
, develop and advance product candidates into, and successfully complete, clinical trials; and our plans and strategy regarding maintaining existing
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
GRTS
1 Apr 24
and OS data readout); and our plans and strategy regarding maintaining existing and entering into new collaborations and/or partnerships
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GRTS
5 Mar 24
; and our plans and strategy regarding maintaining existing and entering into new collaborations and/or partnerships. Such forward-looking statements
- Prev
- 1
- Next